Company launches GenAI clinical support to accelerate care management for Parkinson’s patients and clinicians

Rune Labs — San Francisco-based precision neurology software and data company — has made a significant advancement in the management of Parkinson's disease by launching StrivePD-AI, a Generative Artificial Intelligence (GenAI) tool designed to support patients, caregivers, and clinicians.

The solution delivers automated, HIPAA-compliant monthly reports that synthesize data from multiple sources — including the Apple Watch, patient diaries, and caregiver inputs — to provide a comprehensive view of disease progression. These reports aim to enhance patient care by offering personalized insights and clinical recommendations, filling a critical gap in the availability of specialized care for Parkinson's patients.

How does it work?

Called StrivePD-AI, the solution uses sophisticated GenAI algorithms that merge Anthropic's Claude 3.5 Sonnet Large Language Model (LLM) with Rune Labs' clinical guidelines and curated coaching content. It aggregates multimodal data, which includes patient-reported outcomes such as symptoms, side effects, and activities like walking or yoga logged through Apple Fitness or the StrivePD app.

Patients can also record free text notes on various aspects of their health, such as sleep patterns, mood changes, and blood pressure readings. The AI processes this information to generate monthly reports that provide a clear, consolidated summary of disease progression and personalized coaching tips.

The reports are sent directly to patients via email, offering actionable insights and encouragement to continue tracking their symptoms and experiences. They provide crucial information on medication practices, fall mitigation strategies, cognitive and sleep symptoms, and other important health markers, drawing from the most credible Parkinson's disease resources.

Why does it matter?

The launch of StrivePD-AI addresses a growing problem: the shortage of specialists who can provide adequate care for Parkinson's patients.

"Most Parkinson's patients struggle to get adequate access to care," explained Brian Pepin, CEO of Rune Labs. "There is huge potential in GenAI and Large Language Models to empower patients to take more care into their own hands."

With these AI-driven clinical reports, patients like Kevin, a user from Florida, are already experiencing benefits: "I have already been able to show my report to my provider, who adjusted my medication regimen, decreasing the severity of my tremors during the day," he said.

Further, this technology allows patients and caregivers to make more informed decisions about care between clinician visits.

For instance, caregivers such as Dennis Tinley, who looks after his wife with Parkinson's, find these reports invaluable: "This isn't just about data-it's about empowering us to make informed decisions that can enhance her quality of life."

The context

Parkinson's disease management has long been challenged by limited access to specialized care and the complexities of symptom monitoring. Traditional methods often rely heavily on sporadic clinic visits and patient self-reporting, which can be inconsistent and subjective. The integration of GenAI technology by Rune Labs marks a shift toward more proactive, data-driven approaches to disease management. By leveraging large language models and multimodal data, StrivePD-AI fills a crucial gap, providing a consistent stream of actionable insights and personalized coaching to patients and their support teams.

Rune Labs' commitment to patient-centric care is further demonstrated by its focus on transparency, privacy, and compliance, ensuring that user data is protected and handled responsibly. As the StrivePD-AI technology becomes widely available, it is poised to transform how Parkinson's disease is managed, improving outcomes for patients and easing the burden on healthcare providers.